Visitador Médico: Será que ya no te quieren...?

EVANSTON, IL —May 6, 2010

Obtaining access to busy physicians grew still more difficult for pharmaceutical representatives in 2009, as

the number of physicians willing to see most reps fell nearly 20 percent,

the number of prescribers refusing to see most reps increased by half and the number of management-planned sales calls that were nearly impossible to complete topped 8 million.

These are among the findings of the latest AccessMonitor™, a report from global consulting firm ZS Associates that examines how often physicians and other prescribers will meet with sales representatives from pharmaceutical manufacturers.

The study monitors the sales rep-related interactions of more than 500,000 physicians, nurse practitioners and other pharmaceutical prescribers nationwide and tracks both the planned and completed sales calls of more than 41,000 pharmaceutical representatives — about half of all representatives in the United States.

According to the spring 2010 report of AccessMonitor™,

only slightly more than half (58 percent) of prescribers in 2009 were “rep-accessible;”

that is, they met with at least 70 percent of the sales representatives who called on them. This is down 18 percent from the spring 2009 study that showed 71 percent of physicians met with at least 70 percent of pharmaceutical representatives. At the same time,

the number of “rep-inaccessible” prescribers — those who saw fewer than 30 percent of the reps who called on them — increased to 9 percent from 6 percent.

The report classified

33 percent of physicians as “rep-neutral;

” they’ll see 31 percent to 69 percent of the pharmaceutical salesmen who call on them.

Ver